28th Jul 2010 10:36
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
||||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
ARK THERAPEUTICS GROUP PLC |
|||||||||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||||||||
An acquisition or disposal of voting rights |
x |
|||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||||||||
An event changing the breakdown of voting rights |
|
|||||||||
Other (please specify): |
|
|
||||||||
3. Full name of person(s) subject to the notification obligation:
|
Gartmore Investment Limited |
|||||||||
4. Full name of shareholder(s) (if different from 3.):
|
Registered Owner: BNY GIL CLT Account Nominees Ltd
Beneficial Owner: Gartmore Fledgling Trust PLC |
|||||||||
5. Date of the transaction and date on which the threshold is crossed or reached:
|
23 July 2010 |
|||||||||
6. Date on which issuer notified:
|
27 July 2010 |
|||||||||
7. Threshold(s) that is/are crossed or reached:
|
5% |
|||||||||
8. Notified details: |
||||||||||
A: Voting rights attached to shares
|
||||||||||
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
||||||
Direct |
Direct |
Indirect |
Direct |
Indirect |
||||||
Ordinary GB0034251727 |
- |
- |
10,610,000 |
|
10,610,000 |
|
5.075% |
|||
|
||||||||||
B: Qualifying Financial Instruments |
|||||||||
Resulting situation after the triggering transaction
|
|||||||||
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period |
Number of voting rights that may be acquired if the instrument is exercised/ converted.
|
% of voting rights |
|||||
N/A |
|
|
|
|
|||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
|||||||||
Resulting situation after the triggering transaction
|
|||||||||
Type of financial instrument |
Exercise price |
Expiration date |
Exercise/ Conversion period |
Number of voting rights instrument refers to |
% of voting rights
|
||||
N/A |
|
|
|
|
Nominal |
Delta
|
|||
|
|
||||||||
Total (A+B+C)
|
|||||||||
Number of voting rights |
Percentage of voting rights |
||||||||
10,610,000 |
5.075% |
||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
|||||||||
|
|||||||||
Proxy Voting:
|
|||||||||
10. Name of the proxy holder:
|
|
||||||||
11. Number of voting rights proxy holder will cease to hold:
|
|
||||||||
12. Date on which proxy holder will cease to hold voting rights:
|
|
||||||||
13. Additional information:
|
Email contact: [email protected] |
||||||||
14. Contact name:
|
RDU |
||||||||
15. Contact telephone number:
|
0207 782 2324 |
||||||||
Related Shares:
PVG.L